Page last updated: 2024-11-07

carbachol and Focal Segmental Glomerulosclerosis

carbachol has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bousquet, SM1
Monet, M1
Boulay, G1
Winn, MP1
Conlon, PJ1
Lynn, KL1
Farrington, MK1
Creazzo, T1
Hawkins, AF1
Daskalakis, N1
Kwan, SY1
Ebersviller, S1
Burchette, JL1
Pericak-Vance, MA1
Howell, DN1
Vance, JM1
Rosenberg, PB1

Other Studies

2 other studies available for carbachol and Focal Segmental Glomerulosclerosis

ArticleYear
Protein kinase C-dependent phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition.
    The Journal of biological chemistry, 2010, Dec-24, Volume: 285, Issue:52

    Topics: Amino Acid Substitution; Carbachol; Carcinogens; Cell Proliferation; Glomerulosclerosis, Focal Segme

2010
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.
    Science (New York, N.Y.), 2005, Jun-17, Volume: 308, Issue:5729

    Topics: Amino Acid Substitution; Angiotensin II; Calcium; Calcium Channels; Calcium Signaling; Carbachol; Ce

2005